Dr. Radhika Maddali, MD

NPI: 1790872638
Total Payments
$6,737
2024 Payments
$837.42
Companies
34
Transactions
479
Medicare Patients
1,352
Medicare Billing
$182,666

Payment Breakdown by Category

Food & Beverage$6,636 (98.5%)
Education$101.38 (1.5%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $6,636 461 98.5%
Education $101.38 18 1.5%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $1,388 78 $0 (2024)
Novo Nordisk Inc $1,332 113 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $929.62 75 $0 (2024)
GlaxoSmithKline, LLC. $616.36 44 $0 (2024)
Lilly USA, LLC $511.25 38 $0 (2024)
Merck Sharp & Dohme LLC $442.56 35 $0 (2022)
SANOFI-AVENTIS U.S. LLC $322.94 23 $0 (2023)
Kowa Pharmaceuticals America, Inc. $202.66 15 $0 (2022)
Daiichi Sankyo Inc. $153.14 11 $0 (2021)
ABBVIE INC. $97.76 6 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $837.42 47 AstraZeneca Pharmaceuticals LP ($374.98)
2023 $926.03 62 AstraZeneca Pharmaceuticals LP ($234.16)
2022 $828.92 63 Novo Nordisk Inc ($234.84)
2021 $950.71 71 Novo Nordisk Inc ($243.42)
2020 $735.40 56 Novo Nordisk Inc ($122.96)
2019 $503.40 37 AstraZeneca Pharmaceuticals LP ($131.73)
2018 $890.77 69 Novo Nordisk Inc ($174.10)
2017 $1,065 74 AstraZeneca Pharmaceuticals LP ($298.09)

All Payment Transactions

479 individual payment records from CMS Open Payments — Page 1 of 20

Date Company Product Nature Form Amount Type
12/12/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $14.31 General
Category: Cardiovascular and Metabolism
12/11/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $12.55 General
Category: Diabetes
11/26/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $15.76 General
Category: Respiratory
11/21/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $13.08 General
Category: DIABETES
10/31/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $13.50 General
Category: Diabetes
10/30/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $13.42 General
Category: Respiratory
10/24/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $16.30 General
Category: RESPIRATORY
10/22/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $15.47 General
Category: DIABETES
10/16/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $14.92 General
Category: Respiratory
10/11/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $14.63 General
Category: Cardiovascular and Metabolism
10/08/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $16.01 General
Category: Diabetes
09/25/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $11.72 General
Category: Diabetes
09/18/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $14.74 General
Category: RESPIRATORY
09/13/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $14.41 General
Category: NEUROSCIENCE
09/10/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $15.37 General
Category: DIABETES
09/05/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $14.76 General
Category: Cardiovascular and Metabolism
08/30/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $13.67 General
Category: Diabetes
08/23/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $14.93 General
Category: Diabetes
08/21/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $14.95 General
Category: RESPIRATORY
08/13/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $13.14 General
Category: Inflammation
08/02/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $14.90 General
Category: Cardiovascular and Metabolism
07/30/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $25.59 General
Category: Oncology
07/26/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $15.95 General
Category: Diabetes
07/24/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $13.78 General
Category: Respiratory
07/16/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $15.67 General
Category: DIABETES

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 244 623 $73,435 $41,141
2022 9 333 806 $93,690 $53,094
2021 11 368 799 $81,680 $47,021
2020 11 407 835 $77,460 $41,410
Total Patients
1,352
Total Services
3,063
Medicare Billing
$182,666
Procedure Codes
38

All Medicare Procedures & Services

38 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 49 107 $16,050 $11,540 71.9%
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month Office 2023 22 169 $15,500 $7,805 50.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 48 101 $12,120 $7,352 60.7%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 40 40 $15,510 $5,688 36.7%
99439 Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month Office 2023 20 141 $10,575 $5,523 52.2%
90662 Influenza vaccine split virus, preservative free Office 2023 27 27 $2,160 $1,942 89.9%
G0008 Administration of influenza virus vaccine Office 2023 38 38 $1,520 $1,291 84.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 59 126 $18,900 $13,743 72.7%
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month Office 2022 40 252 $23,500 $11,429 48.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 56 123 $14,760 $9,121 61.8%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 49 49 $19,110 $7,280 38.1%
99439 Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month Office 2022 30 154 $11,500 $6,491 56.4%
90662 Influenza vaccine split virus, preservative free Office 2022 30 30 $2,400 $2,056 85.7%
G0008 Administration of influenza virus vaccine Office 2022 43 45 $1,800 $1,519 84.4%
90682 Influenza vaccine, quadrivalent derived from recombinant dna Office 2022 15 16 $1,280 $1,080 84.4%
G0009 Administration of pneumococcal vaccine Office 2022 11 11 $440.00 $374.75 85.2%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 67 157 $23,550 $16,896 71.7%
99490 Chronic care management services, first 20 minutes of clinical staff time per calendar month Office 2021 50 326 $17,590 $10,183 57.9%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 52 52 $20,280 $7,753 38.2%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 44 68 $7,920 $4,509 56.9%
99439 Chronic care management services, each additional 20 minutes of clinical staff time per calendar month Office 2021 31 72 $4,190 $2,236 53.4%
90662 Vaccine for influenza for injection into muscle, split virus, preservation free Office 2021 30 30 $2,400 $1,954 81.4%
90732 Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older Office 2021 11 11 $1,650 $1,355 82.1%
G0008 Administration of influenza virus vaccine Office 2021 45 45 $1,800 $878.85 48.8%
90682 Vaccine for influenza derived from dna for injection into muscle, quadrivalent, preservative and antibiotic free Office 2021 13 13 $1,040 $848.38 81.6%

About Dr. Radhika Maddali, MD

Dr. Radhika Maddali, MD is a Internal Medicine healthcare provider based in East Orange, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790872638.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Radhika Maddali, MD has received a total of $6,737 in payments from pharmaceutical and medical device companies, with $837.42 received in 2024. These payments were reported across 479 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($6,636).

As a Medicare-enrolled provider, Maddali has provided services to 1,352 Medicare beneficiaries, totaling 3,063 services with total Medicare billing of $182,666. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location East Orange, NJ
  • Active Since 10/10/2006
  • Last Updated 03/20/2013
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1790872638

Products in Payments

  • JARDIANCE (Drug) $680.07
  • FARXIGA (Drug) $646.47
  • Ozempic (Drug) $583.19
  • Rybelsus (Drug) $337.31
  • JANUVIA (Drug) $309.63
  • TRELEGY ELLIPTA (Drug) $267.19
  • BREZTRI (Drug) $242.85
  • ANORO (Drug) $238.24
  • Livalo (Drug) $202.66
  • SYMBICORT (Drug) $187.46
  • STIOLTO RESPIMAT (Drug) $180.18
  • INJECTAFER (Drug) $153.14
  • FASENRA (Biological) $138.24
  • TRULICITY (Drug) $123.79
  • RYBELSUS (Drug) $122.38
  • SEGLUROMET (Drug) $105.63
  • TRADJENTA (Drug) $104.17
  • VRAYLAR (Drug) $97.76
  • Victoza (Drug) $95.34
  • SOLIQUA 100/33 (Biological) $93.82

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in East Orange